| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.091 | 0.06 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.076 | 0.06 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.06 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.059 | 0.07 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.07 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.07 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.07 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | 0.063 | 0.07 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | 0.094 | 0.08 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.063 | 0.08 |